PL394895A1 - Kompozycja gęstego ekstraktu z igieł sosnowych do kapsułkowania - Google Patents

Kompozycja gęstego ekstraktu z igieł sosnowych do kapsułkowania

Info

Publication number
PL394895A1
PL394895A1 PL394895A PL39489509A PL394895A1 PL 394895 A1 PL394895 A1 PL 394895A1 PL 394895 A PL394895 A PL 394895A PL 39489509 A PL39489509 A PL 39489509A PL 394895 A1 PL394895 A1 PL 394895A1
Authority
PL
Poland
Prior art keywords
vitamin
encapsulation
dense
composition
pine needle
Prior art date
Application number
PL394895A
Other languages
English (en)
Other versions
PL217762B1 (pl
Inventor
Juris Rubens
Irena Daberte
Ilze Barene
Maris Daugavietis
Original Assignee
Rigas Stradina Universitate
Bf-Esse, Sia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigas Stradina Universitate, Bf-Esse, Sia filed Critical Rigas Stradina Universitate
Publication of PL394895A1 publication Critical patent/PL394895A1/pl
Publication of PL217762B1 publication Critical patent/PL217762B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Wynalazek dotyczy kompozycji do stymulowania naprawy śluzówki i powłoki wspólnej skóry i do zwiększania odporności organizmu. Kompozycja zawiera α tokoferol (witamina E), retynol (witamina A), naftokwinony (witamina K), konieczne kwasy tłuszczowe (witamina F) i mikroelementy (cynk, selen) w odpowiednim stosunku składników do gęstego ekstraktu z igieł sosnowych do umieszczania w kapsułkach.
PL394895A 2008-12-04 2009-10-01 Kompozycja gęstego ekstraktu z igieł sosnowych do enkapsulacji PL217762B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-08-205A LV13888B (lv) 2008-12-04 2008-12-04 Skuju biezo ekstraktu saturošs sastāvs iekapsulēšanai

Publications (2)

Publication Number Publication Date
PL394895A1 true PL394895A1 (pl) 2011-09-26
PL217762B1 PL217762B1 (pl) 2014-08-29

Family

ID=40775140

Family Applications (1)

Application Number Title Priority Date Filing Date
PL394895A PL217762B1 (pl) 2008-12-04 2009-10-01 Kompozycja gęstego ekstraktu z igieł sosnowych do enkapsulacji

Country Status (8)

Country Link
US (1) US20110280960A1 (pl)
CN (1) CN102264376A (pl)
CA (1) CA2745579C (pl)
FI (1) FI123675B (pl)
LV (1) LV13888B (pl)
NO (1) NO20110884A1 (pl)
PL (1) PL217762B1 (pl)
WO (1) WO2010064882A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2855171A1 (en) * 2011-11-21 2013-05-30 The University Of British Columbia Diterpene synthases and method for producing diterpenoids
CN109380724A (zh) * 2018-12-10 2019-02-26 凃玉英 一种无酒精的红酒胶囊及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU1787440C (ru) * 1990-10-23 1993-01-15 Рижский Медицинский Институт Вещество, обладающее бактерицидным и репаративным действием
RU2137471C1 (ru) * 1996-05-28 1999-09-20 Акционерное общество открытого типа "Уралбиофарм" Масляно-поливитаминный препарат
RU2143212C1 (ru) * 1998-07-29 1999-12-27 Общество с ограниченной ответственностью "Фитолон" Биологически активная добавка
US20030224071A1 (en) * 1999-08-20 2003-12-04 Howard Murad Pharmaceutical compositions and methods for managing connective tissue ailments
EP1527774A1 (en) * 2003-11-03 2005-05-04 Basilea Pharmaceutica AG New formulation for retinoid-containing soft gelatin capsules
JP2007509918A (ja) * 2003-10-30 2007-04-19 リピッド ニュートリション ベスローテン フェンノートシャップ 松葉抽出物
RU2275192C2 (ru) * 2004-05-27 2006-04-27 Закрытое акционерное общество "Алтайвитамины" Витаминно-минеральный комплекс

Also Published As

Publication number Publication date
CA2745579A1 (en) 2010-06-10
NO20110884A1 (no) 2011-06-20
CA2745579C (en) 2018-09-04
LV13888B (lv) 2009-06-20
FI20115698A (fi) 2011-07-01
WO2010064882A1 (ru) 2010-06-10
CN102264376A (zh) 2011-11-30
LV13888A (lv) 2009-03-20
US20110280960A1 (en) 2011-11-17
PL217762B1 (pl) 2014-08-29
FI123675B (fi) 2013-09-13

Similar Documents

Publication Publication Date Title
GB2459809A (en) Fatty acid formulations and methods of use thereof
AR047649A1 (es) Composicion nutricional para mejorar la condicion de la piel e impedir las enfermedades de la piel
CR20110466A (es) Anticuerpos biespecíficos anti-erbb-3/anti-c-met
ES2656438T3 (es) Composición para el tratamiento de enfermedades degenerativas de las articulaciones
ECSP13011139A (es) Anticuerpos contra la angiopoyetina 2 humana
NI201200038A (es) Conjugados de niacina y ácidos grasos y sus usos
BRPI0901553A2 (pt) máscara facial
BR112017000313A2 (pt) sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal
DOP2006000216A (es) Composicion que enmascara el sabor metalico
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
AR090247A1 (es) Composicion de pienso para reducir la metanogenesis en rumiantes
WO2009091183A3 (en) Method for extracting using glacial water and the extract thereof, and cosmetic composition comprising namoemulsion particles having the extract encapsulated or the glacial water.
MX353207B (es) Encapsulacion de ingredientes en matriz de lactosa para formar encapsulados activos.
GB2492680A (en) Oral supplement
AR088056A1 (es) MODULACION DE TIMOSINA b-4 EN LA PIEL, METODO PARA MEJORAR EL ASPECTO ESTETICO DE LA PIEL, PARA TRATAR ARRUGAS, COMPOSICION COSMETICA
BR112012026346A2 (pt) formulações inovadoras de ingredientes (s) ativo(s) de origem vegetal ou seus análogos sintéticos ou de extrato(s) de origem vegetal que os inclui, e de lacitina
ECSP13012799A (es) Uso de composiciones nutricionales que incluyen lactoferrinas para mejorar la resistencia a enfermedades y condiciones
MX2011011860A (es) Composicion estimulante inmune que comprende un extracto de aronia sp. en combinacion con selenio y/o zinc.
GB2467084A (en) Mitigation of animal and plant diseases using bioavailable minerals
HRP20161447T1 (hr) Pripravak koji sadrži ekstrakt zelenog čaja i ekstrakt nara, namijenjen upotrebi u sprječavanju ili usporavanju napredovanja raka prostate
PL394895A1 (pl) Kompozycja gęstego ekstraktu z igieł sosnowych do kapsułkowania
WO2010079910A3 (ko) 기능성 성분을 함유하는 당뇨 또는 당뇨 합병증의 예방 또는 치료 효능을 가지는 시력보호용 조성물
CN103655430A (zh) 一种具有美白功效的面膜
BRPI0712478B8 (pt) uso de material de planta ou extrato do material de planta
BR112012028506A2 (pt) "composições que compreenden extratos de abrótano ( artemisia abrotanum) e um composto de amina"